An SMA project report: Neural cell-based assays derived from human embryonic stem cells

Stem Cells and Development

Volumn 16, Issue 6, 2007, Pages 1027-1041

  Wilson, Patricia G ^a   Cherry, Jonathan J ^c   Schwamberger, Shelle ^a   Adams, Allison M ^a   Zhou, Jianhua ^c   Shin, Soojung ^a,b   Stice, Steven L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b INVITROGEN CORPORATION   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; LUCIFERASE; PLASMID DNA; RECOMBINANT PROTEIN; RETINOIC ACID; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOMEGALOVIRUS; DEGENERATIVE DISEASE; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE CASSETTE; GENE STRUCTURE; GENETIC TRANSFECTION; HEREDITARY SPINAL MUSCULAR ATROPHY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; STEM CELL TRANSPLANTATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

ANEUPLOIDY; CELL ADHESION; CHILD; CHILD, PRESCHOOL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EMBRYONIC STEM CELLS; FEMALE; GENES, REPORTER; HUMANS; INFANT; LUCIFERASES; MUSCULAR ATROPHY, SPINAL; NERVE TISSUE PROTEINS; NEURAL CREST; PLASMIDS; POLYMORPHISM, GENETIC; PREGNANCY; RNA-BINDING PROTEINS; STEM CELL TRANSPLANTATION; TRANSFECTION;

CYTOMEGALOVIRUS;

EID: 37549047938     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0061     Document Type: Article

References (72)

1. Zhang SC, M Wernig, ID Duncan, O Brustle and JA Thomson. (2001). In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nature Biotechnol 19:1129-1133.
2. Nayak MS, YS Kim, M Goldman, HS Keirstead and DA Kerr. (2006). Cellular therapies in motor neuron diseases. Biochim Biophys Acta 1762:1128-1138.
3. Correia AS, SV Anisimov, JY Li and P Brundin. (2005). Stem cell-based therapy for Parkinson's disease. Ann Med 37:487-498.
4. Brodhun M, R Bauer and S Patt. (2004). Potential stem cell therapy and application in neurotrauma. Exp Toxicol Pathol 56:103-112.
5. Nagai M, DB Re, T Nagata, A Chalazonitis, TM Jessell, H Wichterle and S Przedborski. (2007). Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neurosci 10:615-622.
6. Di Giorgio FP, MA Carrasco, MC Siao, T Maniatis and K Eggan. (2007). Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nature Neurosci 10:608-614.
7. Tutter AV, GA Baltus and S Kadam. (2006). Embryonic stem cells: a great hope for a new era of medicine. Curr Opin Drug Discov Devel 9:169-175.
8. Hirtz D, S Iannaccone, J Heemskerk, K Gwinn-Hardy, R Moxley, 3rd and LP Rowland. (2005). Challenges and opportunities in clinical trials for spinal muscular atrophy. Neurology 65:1352-1357.
9. Singh NN, RN Singh and EJ Androphy. (2007). Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res 35:371-389.
10. Singh NN, RN Singh and EJ Androphy. (2006). Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res 35:371-389.
11. Brzustowicz LM, T Lehner, LH Castilla, GK Penchaszadeh, KC Wilhelmsen, R Daniels, KE Davies, M Leppert, F Ziter, D Wood and et al. (1990). Genetic mapping of chronic childhood onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344:540-541.
12. Melki J, S Abdelhak, P Sheth, MF Bachelot, P Burlet, A Marcadet, J Aicardi, A Barois, JP Carriere, M Fardeau and et al. (1990). Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 344:767-768.
13. Lefebvre S, P Burlet, Q Liu, S Bertrandy, O Clermont, A Munnich, G Dreyfuss and J Melki. (1997). Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16:265-269.
14. Monani UR. (2005). Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 48:885-896.
15. Percipalle P and N Visa. (2006). Molecular functions of nuclear actin in transcription. J Cell Biol 172:967-971.
16. Grummt I. (2006). Actin and myosin as transcription factors. Curr Opin Genet Dev 16:191-196.
17. Hofmann WA and P de Lanerolle. (2006). Nuclear actin: to polymerize or not to polymerize. J Cell Biol 172:495-96.
18. Tada T and M Sheng. (2006). Molecular mechanisms of dendritic spine morphogenesis. Curr Opin Neurobiol 16:95-101.
19. Rossoll W, S Jablonka, C Andreassi, AK Kroning, K Karle, UR Monani and M Sendtner. (2003). Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol 163:801-812.
20. Zhang HL, F Pan, D Hong, SM Shenoy, RH Singer and GJ Bassell. (2003). Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci 23:6627-6637.
21. Eggert C, A Chari, B Laggerbauer and U Fischer. (2006). Spinal muscular atrophy: the RNP connection. Trends Mol Med 12:113-121.
22. Giesemann T, S Rathke-Hartlieb, M Rothkegel, JW Bartsch, S Buchmeier, BM Jockusch and H Jockusch. (1999). A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems. J Biol Chem 274:37908-37914.
23. Briese M, B Esmaeili and DB Sattelle. (2005). Is spinal muscular atrophy the result of defects in motor neuron processes? Bioessays 27:946-957.
24. Nicole S, B Desforges, G Millet, J Lesbordes, C Cifuentes-Diaz, D Vertes, ML Cao, F De Backer, L Languille, N Roblot et al. (2003). Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. J Cell Biol 161:571-582.
25. Rajendra TK, GB Gonsalvez, MP Walker, KB Shpargel, HK Salz and AG Matera. (2007). A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle. J Cell Biol 176:831-841.
26. Fan L and LR Simard. (2002). Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum Mol Genet 11:1605-1614.
27. Patrizi AL, F Tiziano, S Zappata, MA Donati, G Neri and C Brahe. (1999). SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 7:301-309.
28. Sumner CJ. (2006). Therapeutics development for spinal muscular atrophy. NeuroRx 3:235-245.
29. Ting CH, CW Lin, SL Wen, HM Hsieh-Li and H Li. (2007). Stat5 constitutive activation rescues defects in spinal muscular atrophy. Hum Mol Genet 16:499-514.
30. van Bergeijk J, K Haastert, C Grothe and P Claus. (2006). Valproic acid promotes neurite outgrowth in PC12 cells independent from regulation of the survival of motoneuron protein. Chem Biol Drug Des 67:244-247.
31. Shin S, Y Sun, Y Liu, H Khaner, S Svant, J Cai, XQ Xu, BP Davidson, SL Stice, AK Smith, SA Goldman, BE Reubinoff, M Zhan, MS Rao and JD Chesnut. (2007). Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells 25:1298-1306.
32. Shin S, S Dalton and SL Stice. (2005). Human motor neuron differentiation from human embryonic stem cells. Stem Cells Dev 14:266-269.
33. Li XJ, ZW Du, ED Zarnowska, M Pankratz, LO Hansen, RA Pearce and SC Zhang. (2005). Specification of motoneurons from human embryonic stem cells. Nature Biotechnol 23:215-221.
34. Mitalipova M, J Calhoun, S Shin, D Wininger, T Schulz, S Noggle, A Venable, I Lyons, A Robins and S Stice. (2003). Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21:521-526.
35. Zhang ML, CL Lorson, EJ Androphy and J Zhou. (2001). An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther 8:1532-1538.
36. Monani UR, JD McPherson and AH Burghes. (1999). Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim Biophys Acta 1445:330-336.
37. Mitalipova MM, RR Rao, DM Hoyer, JA Johnson, LF Meisner, KL Jones, S Dalton and SL Stice. (2005). Preserving the genetic integrity of human embryonic stem cells. Nature Biotechnol 23:19-20.
38. Stone D and A Lieber. (2006). New serotypes of adenoviral vectors. Curr Opin Mol Ther 8:423-431.
39. Bosch P, C Fouletier-Dilling, EA Olmsted-Davis, AR Davis and SL Stice. (2006). Efficient adenoviral-mediated gene delivery into porcine mesenchymal stem cells. Mol Reprod Dev 73:1393-1403.
40. Bosch P, SL Pratt and SL Stice. (2006). Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod 74:46-57.
41. Shin S, M Mitalipova, S Noggle, D Tibbitts, A Venable, R Rao and SL Stice. (2006). Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 24:125-138.
42. Gerrard L, L Rodgers and W Cui. (2005). Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 23:1234-1241.
43. Joannides AJ, C Fiore-Heriche, AA Battersby, P Athauda-Arachchi, IA Bouhon, L Williams, K Westmore, PJ Kemp, A Compston, ND Allen and S Chandran. (2007). A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 25:731-737.
44. Pankratz MT, XJ Li, TM Lavaute, EA Lyons, X Chen and SC Zhang. (2007). Directed neural differentiation of hESCs via an obligated primitive anterior stage. Stem Cells 25:1298-1306.
45. Wilson PG and SS Stice. (2006). Development and differentiation of neural rosettes derived from human embryonic stem cells. Stem Cell Rev 2:67-77.
46. Echaniz-Laguna A, P Miniou, D Bartholdi and J Melki. (1999). The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am J Hum Genet 64:1365-1370.
47. Monani UR, CL Lorson, DW Parsons, TW Prior, EJ Androphy, AH Burghes and JD McPherson. (1999). A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8:1177-1183.
48. Kozak M. (2006). Rethinking some mechanisms invoked to explain translational regulation in eukaryotes. Gene 382:1-11.
49. Ware CB, AM Nelson and CA Blau. (2006). A comparison of NIH-approved human ESC lines. Stem Cells 24:2677-2684.
50. Hoffman LM and MK Carpenter. (2005). Human embryonic stem cell stability. Stem Cell Rev 1:139-144.
51. Zeng X and MS Rao. (2007). Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience 145:1348-1358.
52. Wirth B, L Brichta and E Hahnen. (2006). Spinal muscular atrophy: from gene to therapy. Semin Pediatr Neurol 13:121-131.
53. Van Den Bosch L and V Timmerman. (2006). Genetics of motor neuron disease. Curr Neurol Neurosci Rep 6:423-431.
54. Hausmanowa-Petrusewicz I and G Vrbova. (2005). Spinal muscular atrophy: a delayed development hypothesis. Neuroreport 16:657-661.
55. Ogino S and RB Wilson. (2004). Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn 4:15-29.
56. Wirth B. (2002). Spinal muscular atrophy: state-of-the-art and therapeutic perspectives. Amyotroph Lateral Scler Other Motor Neuron Disord 3:87-95.
57. Sumner CJ, TN Huynh, JA Markowitz, JS Perhac, B Hill, DD Coovert, K Schussler, X Chen, J Jarecki, AH Burghes, JP Taylor and KH Fischbeck. (2003). Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 54:647-654.
58. Brichta L, Y Hofmann, E Hahnen, FA Siebzehnrubl, H Raschke, I Blumcke, IY Eyupoglu and B Wirth. (2003). Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 12:2481-2489.
59. Phiel CJ, F Zhang, EY Huang, MG Guenther, MA Lazar and PS Klein. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741.
60. Chang JG, HM Hsieh-Li, YJ Jong, NM Wang, CH Tsai and H Li. (2001). Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98:9808-9813.
61. Andreassi C, C Angelozzi, FD Tiziano, T Vitali, E De Vincenzi, A Boninsegna, M Villanova, E Bertini, A Pini, G Neri and C Brahe. (2004). Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 12:59-65.
62. Iannaccone ST, SA Smith and LR Simard. (2004). Spinal muscular atrophy. Curr Neurol Neurosci Rep 4:74-80.
63. Jarecki J, X Chen, A Bernardino, DD Coovert, M Whitney, A Burghes, J Stack and BA Pollok. (2005). Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum Mol Genet 14:2003-2018.
64. Rombouts K, T Niki, P Greenwel, A Vandermonde, A Wielant, K Hellemans, P De Bleser, M Yoshida, D Schuppan, M Rojkind and A Geerts. (2002). Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res 278:184-197.
65. Yoshida M, A Matsuyama, Y Komatsu and N Nishino. (2003). From discovery to the coming generation of histone deacetylase inhibitors. Curr Med Chem 10:2351-2358.
66. Lunn MR, DE Root, AM Martino, SP Flaherty, BP Kelley, DD Coovert, AH Burghes, NT Man, GE Morris, J Zhou, EJ Androphy, CJ Sumner and BR Stockwell. (2004). Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol 11:1489-1493.
67. Kelley BP, MR Lunn, DE Root, SP Flaherty, AM Martino and BR Stockwell. (2004). A flexible data analysis tool for chemical genetic screens. Chem Biol 11:1495-1503.
68. Andreassi C, J Jarecki, J Zhou, DD Coovert, UR Monani, X Chen, M Whitney, B Pollok, M Zhang, E Androphy and AH Burghes. (2001). Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10:2841-2849.
69. Grzeschik SM, M Ganta, TW Prior, WD Heavlin and CH Wang. (2005). Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 58:194-202.
70. Cashman NR, HD Durham, JK Blusztajn, K Oda, T Tabira, IT Shaw, S Dahrouge and JP Antel. (1992). Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194:209-221.
71. Baron-Delage S, A Abadie, A Echaniz-Laguna, J Melki and L Beretta. (2000). Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes. Mol Med 6:957-968.
72. Majumder S, S Varadharaj, K Ghoshal, U Monani, AH Burghes and ST Jacob. (2004). Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene. J Biol Chem 279:14803-14811.